In addition, targeting a coactivator of CREB, CREB-binding protein (CBP) that forms a CREB/CBP complex and initiates gene transcription, exhibited a higher antiproliferative effect in myeloma cells compared to traditional inhibitors (Vannam et al., 2021). Here, CREBBP is linked to plasma cell myeloma.